Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents

Show simple item record

dc.contributor.author Said M.M.
dc.contributor.author Taher A.T.
dc.contributor.author El-Nassan H.B.
dc.contributor.author El-Khouly E.A.
dc.contributor.other Pharmaceutical Organic Chemistry Department
dc.contributor.other Faculty of Pharmacy
dc.contributor.other Cairo University
dc.contributor.other 33 Kasr El-Aini Street
dc.contributor.other Cairo
dc.contributor.other 11562
dc.contributor.other Egypt; Organic chemistry Department
dc.contributor.other Faculty of Pharmacy
dc.contributor.other October University for Modern Sciences and Arts (MSA)
dc.contributor.other Giza
dc.contributor.other Egypt
dc.date.accessioned 2020-01-09T20:41:36Z
dc.date.available 2020-01-09T20:41:36Z
dc.date.issued 2016
dc.identifier.issn 9226168
dc.identifier.other https://doi.org/10.1007/s11164-016-2487-x
dc.identifier.other PubMed ID :
dc.identifier.uri https://t.ly/2dre5
dc.description Scopus
dc.description.abstract Abstract: Two series of 4-phenyl-5-cyanopyrimidin-6-one derivatives bearing various S-alkyl or S-acyl moieties at position 2 were prepared as cytotoxic agents. All compounds were tested for possible anti-cancer activity on two cell lines (MCF-7 and HCT-116). The MCF-7 cell line was found to be more sensitive than the HCT-116 cell line to the action of the compounds. Compound 8g was the most potent on the MCF-7 cell line with IC50 18.3�nM/mL, whereas its IC50 on the normal cell line (MRC-5) was 64.38�nM/mL, indicating its safety and selectivity towards the MCF-7 cell line. On the other hand, compound 8d was the most potent compound on the HCT-116 cell line with IC50 23.8�nM/mL. Compound 8g was screened against five kinases. The compound showed selective inhibitory activity against pim1 kinase with IC50 11.62��M. Graphical Abstract: [Figure not available: see fulltext.] � 2016, Springer Science+Business Media Dordrecht. en_US
dc.description.uri https://www.scimagojr.com/journalsearch.php?q=21492&tip=sid&clean=0
dc.language.iso English en_US
dc.publisher Springer Netherlands en_US
dc.relation.ispartofseries Research on Chemical Intermediates
dc.relation.ispartofseries 42
dc.subject Antitumor activity en_US
dc.subject HCT-116 en_US
dc.subject MCF-7 en_US
dc.subject pim1 en_US
dc.subject Pyrimidine en_US
dc.subject Cell culture en_US
dc.subject Cytology en_US
dc.subject Enzymes en_US
dc.subject Anti-tumor activities en_US
dc.subject HCT-116 en_US
dc.subject MCF-7 en_US
dc.subject pim1 en_US
dc.subject Pyrimidine en_US
dc.subject Cells en_US
dc.title Synthesis of novel S-acyl and S-alkylpyrimidinone derivatives as potential cytotoxic agents en_US
dc.type Article en_US
dcterms.isReferencedBy (2015) JAMA Oncol., 1, p. 505; Bixby, D., Talpaz, M., (2010) Leukemia, 25, p. 7; Palasz, A., Ciez, D., (2014) Eur. J. Med. Chem., 97, p. 582; Fargualy, A.M., Habib, N.S., Ismail, K.A., Hassan, A.M.M., Sarg, M.T.M., (2013) Eur. J. Med. Chem., 66, p. 276. , COI: 1:CAS:528:DC%2BC3sXht1SktbjM; Mai, A., Perrone, A., Nebbioso, A., Rotili, D., Valente, S., Tardugno, M., Massa, S., Altucci, L., (2008) Bioorg. Med. Chem. Lett., 18, p. 2530. , COI: 1:CAS:528:DC%2BD1cXks1aksb4%3D; Abdel-Mohsen, H.T., Ragab, F.A.F., Ramla, M.M., El Diwani, H.I., (2010) Eur. J. Med. Chem., 45, p. 2336. , COI: 1:CAS:528:DC%2BC3cXkvFeisLs%3D; Taher, A.T., Abou-Seri, S.M., (2012) Molecules, 17, p. 9868. , COI: 1:CAS:528:DC%2BC38Xht1KhsbnM; Chen, P.-J., Yang, A., Gu, Y.-F., Zhang, X.-S., Shao, K.-P., Xue, D.-Q., He, P., Liu, H.-M., (2014) Bioorg. Med. Chem. Lett., 24, p. 2741. , COI: 1:CAS:528:DC%2BC2cXntlyjs78%3D; Shao, K.-P., Zhang, X.-Y., Chen, P.-J., Xue, D.-Q., He, P., Ma, L.-Y., Zheng, J.-X., Liu, H.-M., (2014) Bioorg. Med. Chem. Lett., 24, p. 3877. , COI: 1:CAS:528:DC%2BC2cXhtFWnsL3J; Ramiz, M.M.M., El-Sayed, W.A., Hagag, E., Abdel-Rahman, A.A.H., (2011) J. Heterocycl. Chem., 48, p. 1028. , COI: 1:CAS:528:DC%2BC3MXht1Wku7%2FL; Rajak, H., Kumar, P., Parmar, P., Thakur, B.S., Veerasamy, R., Sharma, P.C., Sharma, A.K., Dangi, J.S., (2012) Eur. J. Med. Chem., 53, p. 390. , COI: 1:CAS:528:DC%2BC38XnvVygt7o%3D; Harvill, E.K., Herbst, R.M., Schreiner, E.G., (1952) J. Org. Chem., 17, p. 1597. , COI: 1:CAS:528:DyaG2cXnt1Sh; Unger, Y., Strassner, T., (2012) J. Organomet. Chem., 713, p. 203. , COI: 1:CAS:528:DC%2BC38XptF2gur8%3D; Sakurai, G., Matsui, E., (1965) Chem. Pharm. Bull., 13, p. 594. , COI: 1:CAS:528:DyaF2MXktlWltLc%3D; Dalalian, H.P., Rutherford, N.J., (1957) S. Kushner, U.S. patent, 2,807, p. 617; Ganguly, S., Vishwanathan, R., Chandra, R., (2009) J. Inst. Chem., 81, p. 57. , COI: 1:CAS:528:DC%2BD1MXhsVagtbbO; Devegowda, V.N., Seo, S.H., Pae, A.N., Nam, G., Choi, K.I., (2012) Bull. Korean Chem. Soc., 33, p. 647. , COI: 1:CAS:528:DC%2BC38XktFOmu7w%3D; Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Boyd, M.R., (1990) J. Natl Cancer Inst., 82, p. 1107. , COI: 1:CAS:528:DyaK3cXltVylsL8%3D; Xia, Z., Knaak, C., Ma, J., Beharry, Z.M., McInnes, C., Wang, W., Kraft, A.S., Smith, C.D., (2009) J. Med. Chem., 52, p. 74. , COI: 1:CAS:528:DC%2BD1cXhsFSjur%2FM; Uehara, F., Shoda, A., Aritomo, K., Fukunaga, K., Watanabe, K., Ando, R., Shinoda, M., Niwa, T., (2013) Bioorg. Med. Chem. Lett., 23, p. 6928. , COI: 1:CAS:528:DC%2BC3sXhsFynu7%2FL; Al-Suwaidan, I.A., Alanazi, A.M., Abdel-Aziz, A.A.-M., Mohamed, M.A., El-Azab, A.S., (2013) Bioorg. Med. Chem. Lett., 23, p. 3935. , COI: 1:CAS:528:DC%2BC3sXnvV2kurs%3D; Chatterjee, A., Cutler, S.J., Doerksen, R.J., Khan, I.A., Williamson, J.S., (2014) Bioorg. Med. Chem., 22, p. 6409. , COI: 1:CAS:528:DC%2BC2cXhs1yls7vK; Drygin, D., Haddach, M., Pierre, F., Ryckman, D.M., (2012) J. Med. Chem., 55, p. 8199. , COI: 1:CAS:528:DC%2BC38Xht1OmtL7J; Nawijn, M.C., Alendar, A., Berns, A., (2011) Nat. Rev. Cancer, 11, p. 23. , COI: 1:CAS:528:DC%2BC3cXhsFCjsrjE; Merke, A.L., Meggers, E., Ocker, M., (2012) Expert Opin. Investig. Drugs, 21, p. 425; Morwick, T., (2010) Exp. Opin. Ther. Patents, 20, p. 193. , COI: 1:CAS:528:DC%2BC3cXhtVGktbg%3D; Arunesh, G.M., Shanthi, E., Krishna, M.H., Kumar, J.S., Viswanadhan, V.N., (2014) Exp. Opin. Ther. Patents, 24, p. 5. , COI: 1:CAS:528:DC%2BC3sXhvFSlurvM; Inc. 6-Phenylpyrimidinones as Pim modulators (2008) WO2008133955
dcterms.source Scopus
dc.identifier.doi https://doi.org/10.1007/s11164-016-2487-x
dc.identifier.doi PubMed ID :
dc.Affiliation October University for modern sciences and Arts (MSA)


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search MSAR


Advanced Search

Browse

My Account